Literature DB >> 17979750

Expression of defensins in gingiva and their role in periodontal health and disease.

W O Chung1, H Dommisch, L Yin, B A Dale.   

Abstract

Oral epithelium is a stratified squamous epithelium that functions as the barrier between the outside environment and the host. In the oral cavity, epithelial tissues are constantly exposed to a variety of bacteria, but most individuals maintain healthy homeostasis. Epithelial cells contribute to the innate host response, and antimicrobial peptide expression in all human epithelia, including oral epithelia, is an important part of this epithelial function. These antimicrobial peptides have a broad spectrum of activity against both Gram-negative and Gram-positive bacteria as well as against yeast and viruses. In humans these antimicrobial peptides include defensins and a cathelicidin family member LL-37 in skin and oral mucosa and other epithelia. The human defensins include the alpha-defensins of intestinal and neutrophil origin, and the beta-defensins of skin and oral mucosa and other epithelia. Present studies have identified specific signaling routes that pathogens and commensals take in stimulating these innate immune responses, and this may open the way for development of new therapeutic agents for periodontal diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979750     DOI: 10.2174/138161207782110435

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  27 in total

Review 1.  Neutrophils in periodontal inflammation.

Authors:  David A Scott; Jennifer Krauss
Journal:  Front Oral Biol       Date:  2011-11-11

Review 2.  Periodontitis: a polymicrobial disruption of host homeostasis.

Authors:  Richard P Darveau
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

3.  Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat.

Authors:  Tara L Aghaloo; Ben Kang; Eric C Sung; Michael Shoff; Matthew Ronconi; Jack E Gotcher; Olga Bezouglaia; Sarah M Dry; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

4.  Nicotine induces upregulated expression of beta defensin-2 via the p38MAPK pathway in the HaCaT human keratinocyte cell line.

Authors:  Sumiko Nakamura; Masato Saitoh; Mami Yamazaki; Michiko Nishimura; Yoshihito Kurashige; Toshiya Arakawa; Taishin Takuma; Tohru Kaku; Yoshihiro Abiko
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

Review 5.  Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis.

Authors:  Sumita Jain; Richard P Darveau
Journal:  Periodontol 2000       Date:  2010-10       Impact factor: 7.589

6.  Effect of growth factors on antimicrobial peptides and pro-inflammatory mediators during wound healing.

Authors:  H Dommisch; J Winter; W Götz; J Miesen; A Klein; L Hierse; J Deschner; A Jäger; J Eberhard; S Jepsen
Journal:  Clin Oral Investig       Date:  2014-05-07       Impact factor: 3.573

Review 7.  The roles of antimicrobial peptides in innate host defense.

Authors:  Gill Diamond; Nicholas Beckloff; Aaron Weinberg; Kevin O Kisich
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Differential and coordinated expression of defensins and cytokines by gingival epithelial cells and dendritic cells in response to oral bacteria.

Authors:  Lei Yin; Takahiro Chino; Orapin V Horst; Beth M Hacker; Edward A Clark; Beverly A Dale; Whasun O Chung
Journal:  BMC Immunol       Date:  2010-07-09       Impact factor: 3.615

9.  Phospholipase C, p38/MAPK, and NF-kappaB-mediated induction of MIP-3alpha/CCL20 by Porphyromonas gingivalis.

Authors:  Henrik Dommisch; Whasun O Chung; Søren Jepsen; Beth M Hacker; Beverly A Dale
Journal:  Innate Immun       Date:  2009-08-26       Impact factor: 2.680

10.  Low-level lasers as an adjunct in periodontal therapy in patients with diabetes mellitus.

Authors:  Radmila Obradović; Ljiljana Kesić; Dragan Mihailović; Goran Jovanović; Slobodan Antić; Zlata Brkić
Journal:  Diabetes Technol Ther       Date:  2012-09       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.